NCT05526924 2026-03-04
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
University of Chicago
Phase 1 Recruiting
Clinical Trials
7 trialsNCT07010120 2025-06-13
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 1/2 Recruiting
NCT06673693 2025-04-16
NEOSTART
Sun Yat-sen University
Phase 2 Recruiting
NCT06258811 2025-03-13
Neoadjuvant Immunochemotherapy for LAOSCC
Huashan Hospital
Phase 3 Recruiting
NCT06741982 2024-12-19
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
West China Hospital
Phase 1 Recruiting
NCT05862168 2023-07-17
Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial
Zhejiang University
Phase 2 Recruiting
NCT05343325 2022-12-29
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Recruiting